ACHE and obesity disorder: Cholinergic compounds, including α7nAChR agonists and centrally acting acetylcholinesterase inhibitors (AChE), have also been shown to alleviate inflammation and metabolic derangements in obesity and MetS (Pavlov and Tracey, 2012).